Navigating joint HTA, procurement, and fair pricing: evidence-based insights and practical recommendations - A meeting report from ISPOR regional conference in Warsaw, 2019

Abstract

Introduction: The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) organized its first Central Eastern European regional meeting in 2019 in Warsaw, Poland. Area covered: The scientific program of the two-day conference covered a broad range of topics presented from the perspective of the region. Specifically, the focus was on cross-country collaboration within different steps of health technology assessment (HTA) and the need for local HTA adaptations in decision-making. Expert commentary: Attended by approximately 200 delegates from many countries and by several high level ISPOR leaders, the conference provided a valuable opportunity to exchange knowledge and strengthen the scientific network among experts from different stakeholder groups on issues specific to the region. ARTICLE HISTORY

The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries

“…Information Classification: General usefulness of information from the Core Model also has been explored in various ways [65,66]. For example, a representative of the Hungarian HTA Office recently stated that in their experience, using joint assessments did reduce the workload on their employees, and allowed them to dedicate more efforts towards the economic aspects of submissions [67]. Another example is Croatia which, despite its limited human and financial resources, already have lots of experience in production of joint rapid REAs on the EU level.…”

“…If a sustainable European system of joint REAs will be established in line with the recent EC proposal, it will likely reduce the workload on the local HTA agencies of European Union member states which can then divert more attention to the non-transferable elements, such as cost-effectiveness assessments, of HTA reports [67]. or take up other activities (e.g.…”

European cooperation in health technology assessment implementation: the perspective of Central and Eastern European countries

“…An example of such a solution is the HTA Core Model [5,17], in which a joint European REA provides the basis for national appraisals. Local HTA doers therefore can focus their efforts on the nontransferable domains of HTA [18], reducing the amount of resources needed to generate appropriate evidence to support policy decisions of new health technologies. In addition, joint REAs can potentially increase the negotiating power of Europe in the global arena of pharmaceutical research and development [19].…”